LYTIR

Company · GMED

Globus Medical, Inc.

Name as listed on its exchange; filed with the SEC as GLOBUS MEDICAL INC.

Nasdaq's symbol directory lists GMED on the New York Stock Exchange as “Globus Medical, Inc. Class A Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 3 occasions ($4.8M); 2 planned-sale notices; 2 filings by holders of 5% or more; 3 congressional trade disclosures; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $4.8M in total.Aug: Insider sales $2.2MSep: Insider sales $2.2MNov: Insider sales $425KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $4.8M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. TOBIN JAMES R sold on 1 day latest Sep 15, 2026 sold $2.2M
  2. ZARRILLI STEPHEN T sold on 1 day latest Aug 18, 2026 sold $2.2M
  3. RHOADS ANN D sold on 1 day all under a 10b5-1 plan latest Nov 4, 2026 sold $425K
Every trade (3)
  1. SELLRHOADS ANN D sold Nov 4, 2026 5,000 shares 10b5-1 plan (scheduled) filing $425K
  2. SELLTOBIN JAMES R sold Sep 15, 2026 30,000 shares filing $2.2M
  3. SELLZARRILLI STEPHEN T sold Aug 18, 2026 25,000 shares filing $2.2M

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. RHOADS ANN D filed Nov 4, 2026 Director 5,000 shares planned sale date 11/04/2026 filing $425K
  2. TOBIN JAMES R filed Sep 15, 2026 Director 30,000 shares planned sale date 09/15/2026 filing $2.2M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Vanguard Capital Management filed Oct 30, 2026 Schedule 13G/A passive 5,960,866 shares filing 4.43%
  2. BlackRock, Inc. filed Oct 27, 2026 Schedule 13G/A passive 10,704,283 shares filing 8%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Gilbert Cisneros (D-CA31): Purchase Sep 3, 2026 reported Oct 12, 2026 one of 57 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  2. Gilbert Cisneros (D-CA31): Purchase Aug 19, 2026 reported Sep 10, 2026 one of 58 trades the member reported that day House Stocks (including ADRs) $15,001 - $50,000
  3. Gilbert Cisneros (D-CA31): Purchase Mar 3, 2026 reported Apr 7, 2026 one of 141 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition; Other events filing Nov 5, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.